【摘 要】
：
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common form of de-mentia worldwide. As age is the main risk factor, > 97% of
【机 构】
：
Laboratory of Psychiatry and Experimental Alzheimer’s Research, Medical University of Innsbruck, Inn
论文部分内容阅读
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common form of de-mentia worldwide. As age is the main risk factor, > 97% of all AD cases are of sporadic origin, potentiated by various risk factors associated with life style and starting at an age > 60 years. Only < 3% of AD cases are of genetic origin caused by mutations in the amyloid precursor protein or Presenilins 1 or 2, and symptoms already start at an age < 30 years. In order to study progression of AD, as well as therapeutic strategies, mouse models are state-of-the-art. So far many transgenic mouse models have been developed and used, with mutations in the APP or presenilin or combinations (3×Tg, 5×Tg). However, such transgenic mouse models more likely mimic the genetic form of AD and no information can be given how sporadic forms develop. Several risk genes, such as Apolipoprotein E4 and TREM-2 enhance the risk of sporadic AD, but also many risk factors associated with life style (e.g., diabetes, hypercholesterolemia, stress) may play a role. In this review we discuss the current situation regarding AD mouse models, and the problems to develop a sporadic mouse model of AD.
其他文献
Over the past decades, tRNA was found to be a rich hub of RNA modifications such as 1-methyladenosine and 5-methycytosine modifications and others, holding more
Increased microvessel density in the peri-infarct region has been reported and has been correlated with longer survival times in ischemic stroke patients and ha
Given the failure to develop disease-modifying therapies for Alzheimer’s disease (AD), strategies aiming at preventing or delaying the onset of the disease are
Since the discovery of the presence of fibrillary forms of α-synuclein (α-syn) in Lewy bodies (LB) and Lewy neurites in the brain of patients affected by Park
There is no effective treatment to face Alzheimer’s disease complexity. Multitarget molecules are a good ap-proach against the multiple physiopathological even
Worldwide stroke is increasing in parallel with modernization, changes in lifestyle, and the growing elderly population. Our review is focused on the link betwe
The last decades have represented an important season in the re-con-ceptualization of brain plasticity, especially in extending the concept at events occurring
Neurological disorders including neurodegeneration (e.g., Alzheimer’s disease and Parkinson’s disease) and acute injuries (e.g., stroke and trau-matic brain i
Investigating the cellular and molecular mechanisms involved in the development of topographically or-dered connections in the central nervous system constitute
Alzheimer’s disease (AD) is a neurodegenerative disease with long preclinical phase, typically followed by a slow decline in memory, thinking and reasoning abi